PAM
CELUW icon

Panagora Asset Management’s Celularity Inc CELUW Stock Holding History

Panagora Asset Management’s Portfolio CELUW Stock Details CELUW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-7,881
Closed -$23K – 2829
2020
Q4 		$23K Sell
7,881
-447
-5% -$837 ﹤0.01% 2172
2020
Q3 		$13K Buy
+8,328
New +$12.6K ﹤0.01% 2280

Other funds holding CELUW

LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
EC
EJF Capital Arlington, Virginia $142M AUM 23.3% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

Panagora Asset Management's CELUW Position: Q1 2021 in Review

Panagora Asset Management sold out of Celularity Inc (CELUW) in Q1 2021, closing a stake of 7,881 shares — an estimated $23K sold.

Panagora Asset Management first reported a position in CELUW in Q3 2020 and held it in 2 quarters. The position peaked at $23K in Q4 2020. 23 funds tracked by Wall St. Rank hold CELUW as of Q1 2021.

  • Panagora Asset Management reported no remaining Celularity Inc position as of Q1 2021 after selling out during the quarter.
  • Panagora Asset Management sold 7,881 Celularity Inc shares in Q1 2021, an estimated $23K.
  • Panagora Asset Management first reported a position in Celularity Inc in Q3 2020 and held it in 2 quarters.
  • Panagora Asset Management's Celularity Inc position peaked at $23K in Q4 2020.
  • 23 funds tracked by Wall St. Rank held Celularity Inc as of Q1 2021.

Based on Panagora Asset Management's 13F filing for Q1 2021, filed 12 May 2021.